Capital CS Group, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital CS Group, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$146,509
-66.3%
17,5250.0%0.17%
-60.0%
Q2 2023$435,321
+65.2%
17,5250.0%0.43%
+73.9%
Q1 2023$263,576
+27.1%
17,5250.0%0.25%
+8.7%
Q4 2022$207,321
+99.3%
17,5250.0%0.23%
+104.5%
Q3 2022$104,000
+40.5%
17,5250.0%0.11%
+45.5%
Q2 2022$74,000
-55.7%
17,5250.0%0.08%
-46.9%
Q1 2022$167,000
-60.5%
17,525
-21.1%
0.14%
-56.3%
Q4 2021$423,000
-34.7%
22,2250.0%0.33%
-44.8%
Q3 2021$648,00022,2250.60%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders